{"filing":{"accession_number":"0001104659-26-085086","cik":"0001725255","ticker":"AHCO","company_name":"AdaptHealth Corp.","form":"8-K","filing_date":"2026-07-20","report_date":null,"primary_document":"tm2620877d1_8k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1725255/000110465926085086/tm2620877d1_8k.htm"},"events":[{"id":18837,"run_id":16948,"accession_number":"0001104659-26-085086","anchor_item_number":"1.01","event_type":"ma_activity","event_domain":"operational","is_material":true,"confidence":0.98,"summary":"AdaptHealth entered into a definitive asset purchase agreement on July 19, 2026, to divest its Diabetes Health business to Cardinal Health (a subsidiary of RGH Enterprises, LLC) for $235 million in cash. This is a material disposition of a business segment, disclosed under Item 1.01 (Entry Into a Material Definitive Agreement). The transaction is described as \"the latest – and most significant – step\" in the company's portfolio restructuring and will materially affect the company's revenue, EBITDA margins, and capital structure going forward, with the Diabetes Health segment to be treated as discontinued operations.","company_name":"AdaptHealth Corp.","ticker":"AHCO","filing_date":"2026-07-20","form":"8-K","submitted_at":null,"items":[{"id":17766,"accession_number":"0001104659-26-085086","item_number":"1.01","item_title":"Entry Into a Material Definitive Agreement.","event_type":"ma_activity","event_domain":"operational","is_material":true,"confidence":0.98,"reasoning":"AdaptHealth entered into a definitive asset purchase agreement on July 19, 2026, to divest its Diabetes Health business to Cardinal Health (a subsidiary of RGH Enterprises, LLC) for $235 million in cash. This is a material disposition of a business segment, disclosed under Item 1.01 (Entry Into a Material Definitive Agreement). The transaction is described as \"the latest – and most significant – step\" in the company's portfolio restructuring and will materially affect the company's revenue, EBITDA margins, and capital structure going forward, with the Diabetes Health segment to be treated as discontinued operations.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-20T20:36:38.009589+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":17766,"accession_number":"0001104659-26-085086","item_number":"1.01","item_title":"Entry Into a Material Definitive Agreement.","event_type":"ma_activity","event_domain":"operational","is_material":true,"confidence":0.98,"reasoning":"AdaptHealth entered into a definitive asset purchase agreement on July 19, 2026, to divest its Diabetes Health business to Cardinal Health (a subsidiary of RGH Enterprises, LLC) for $235 million in cash. This is a material disposition of a business segment, disclosed under Item 1.01 (Entry Into a Material Definitive Agreement). The transaction is described as \"the latest – and most significant – step\" in the company's portfolio restructuring and will materially affect the company's revenue, EBITDA margins, and capital structure going forward, with the Diabetes Health segment to be treated as discontinued operations.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-20T20:36:38.009589+00:00","company_name":"AdaptHealth Corp.","ticker":"AHCO","filing_date":"2026-07-20"}]}